M. Schlaak

发表

S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 1: Epidemiology, Genetics and Diagnosis

M. Weichenthal, A. Hauschild, A. Blum, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Clinical determinants of long-term survival in metastatic uveal melanoma

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancer Immunology, Immunotherapy.

Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases.

J. Landsberg, N. Galldiks, K. Langen, 2016, Neuro-Oncology.

Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment

S. Marnitz, M. Ruge, D. Rueß, 2018, International journal of molecular sciences.

Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.

J. Utikal, S. Haferkamp, D. Schadendorf, 2021, European journal of cancer.

CD30+ anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma with an unusual translocation t(11;22)

J. Simon, C. Wittekind, S. Grunewald, 2008, The British journal of dermatology.

Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: a systematic review.

S. Theurich, N. Skoetz, M. von Bergwelt-Baildon, 2013, Critical reviews in oncology/hematology.

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG

M. Weichenthal, J. Utikal, C. Berking, 2020, Journal for ImmunoTherapy of Cancer.

Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat, how shall we treat? A review of the literature

R. Stadler, M. Schlaak, E. Dippel, 2017, The British journal of dermatology.

Single-slice CT measurements allow for accurate assessment of sarcopenia and body composition

David Zopfs, Jan Borggrefe, Nils Große Hokamp, 2019, European Radiology.

Evaluating body composition by combining quantitative spectral detector computed tomography and deep learning-based image segmentation.

D. Maintz, S. Haneder, S. Theurich, 2020, European journal of radiology.

Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.

M. Hallek, S. Theurich, A. Shimabukuro-Vornhagen, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mast cells play a protumorigenic role in primary cutaneous lymphoma.

R. Büttner, S. Theurich, M. von Bergwelt-Baildon, 2012, Blood.

Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma

T. Schmid, S. Theurich, M. von Bergwelt-Baildon, 2016, Cancer Immunology Research.

Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients

C. Berking, C. Mauch, M. Schlaak, 2021, Journal of immunotherapy.

Indolent Cutaneous T-Cell Lymphomas

S. Theurich, R. Willemze, M. Schlaak, 2021 .

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

A. Enk, C. Berking, S. Haferkamp, 2020, Journal of Cancer Research and Clinical Oncology.

Hematological immune related adverse events after treatment with immune checkpoint inhibitors.

C. Berking, A. Gesierich, K. Kähler, 2021, European journal of cancer.

Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma

G. Fink, N. Galldiks, M. Malter, 2019, Front. Oncol..

Should we be combining local tumor therapies with immunotherapies as standard?

S. Theurich, M. von Bergwelt-Baildon, M. Schlaak, 2017, Future oncology.

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.

R. Sullivan, R. Dummer, J. Kirkwood, 2021, The New England journal of medicine.

Overall survival benefit from tebentafusp in patients with best response of progressive disease.

R. Sullivan, R. Dummer, J. Kirkwood, 2021 .

Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene

M. Schlaak, P. Kurschat, C. Mauch, 2012, Case Reports in Dermatology.

Two Cases of Primary Cutaneous Lymphoma With a g/d+ Phenotype and an Indolent Course: Further Evidence of Heterogeneity of Cutaneous g/d+ T-Cell Lymphomas

M. Schlaak, W. Kempf, D. Kazakov, 2019 .

Two cases of primary cutaneous lymphoma with a γ/δ+ phenotype and an indolent course: further evidence of heterogeneity of cutaneous γ/δ+ T-cell lymphomas.

M. Schlaak, W. Kempf, D. Kazakov, 2014, The American Journal of dermatopathology.

Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T‐cell lymphoma – a case series of the ADF working group „cutaneous lymphomas”

C. Klemke, S. Terras, U. Hegenbart, 2014, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

A pregnant woman with chronic meningococcaemia from Neisseria meningitidis with lpxL1-mutations

M. Schlaak, G. Plum, O. Persa, 2014, The Lancet.

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.

A. Gesierich, K. Kähler, S. Ugurel, 2022, European journal of cancer.

Primary Biliary Cirrhosis and Granulomatous Hepatitis After Immune Checkpoint Blockade in Patients With Metastatic Melanoma: Report of 2 Cases and Literature Discussion.

C. Berking, L. French, C. Ruini, 2020, Journal of immunotherapy.

S2k Guidelines – Cutaneous Lymphomas Update 2016 – Part 2: Treatment and Follow‐up (ICD10 C82 ‐ C86)

D. Mestel, M. Weichenthal, J. Becker, 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells.

H. Abken, M. Schlaak, P. Kurschat, 2012 .

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma

L. Heinzerling, L. French, M. Schlaak, 2022, Cancers.

Model soups improve performance of dermoscopic skin cancer classifiers.

Jakob Nikolas Kather, R. Maron, J. Utikal, 2022, European journal of cancer.

Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma

M. Niyazi, M. Schlaak, M. Dorostkar, 2022, Neuro-oncology advances.

Regression of metastatic melanoma by targeting cancer stem cells

H. Abken, M. Schlaak, P. Kurschat, 2012, Oncotarget.

Oral graft‐versus‐host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus

J. Simon, H. Al-Ali, M. Schlaak, 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow‐up

M. Weichenthal, A. Hauschild, A. Blum, 2019, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Electrochemotherapy in advanced skin tumors and cutaneous metastases – a retrospective multicenter analysis

R. Herbst, C. Assaf, M. Schlaak, 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma].

C. Cursiefen, L. Heindl, M. Schlaak, 2015, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.

D. Schadendorf, P. Jansen, K. Kähler, 2022, European journal of cancer.

Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors.

S. Marnitz, R. Semrau, S. Theurich, 2017, Immunotherapy.

Clinical determinants of long-term survival in metastatic uveal melanoma

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancer Immunology, Immunotherapy.

The Role of Immune Checkpoint Blockade in Uveal Melanoma

C. Berking, M. Heppt, L. Heinzerling, 2020, International journal of molecular sciences.

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.

A. Enk, B. Schilling, Douglas B. Johnson, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021

M. Weichenthal, U. Wehkamp, C. Klemke, 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021

M. Weichenthal, U. Wehkamp, J. Becker, 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients

M. Hallek, K. Kreuzer, M. Schlaak, 2020, Scientific Reports.

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

J. Utikal, C. Berking, A. Gesierich, 2019, Journal of Immunotherapy for Cancer.

UVA (UVA-1) therapy for the treatment of acute GVHD of the skin

D. Niederwieser, J. Simon, H. Al-Ali, 2010, Bone Marrow Transplantation.

Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation.

S. Theurich, A. Shimabukuro-Vornhagen, J. Chemnitz, 2011, Transplant immunology.

(68)Ga-DotaTATE PET-CT followed by Peptide Receptor Radiotherapy in combination with capecitabine in two patients with Merkel Cell Carcinoma.

M. Dietlein, R. Baum, M. Schlaak, 2012, International journal of clinical and experimental medicine.

Guidelines for uveal melanoma: a critical appraisal of systematically identified guidelines using the AGREE II and AGREE-REX instrument

C. Berking, M. Heppt, M. Schlaak, 2020, Journal of Cancer Research and Clinical Oncology.

Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts.

Jakob Nikolas Kather, Roman C. Maron, H. Haenssle, 2021, European journal of cancer.

[Vismodegib therapy for a large basal cell carcinoma on the midface with orbital involvement].

E. Sattler, J. Srour, M. Schlaak, 2020, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single‐centre investigation of 141 patients

E. Wardelmann, R. Büttner, M. Schlaak, 2013, The British journal of dermatology.

Immunotherapy Bridge 2021 and Melanoma Bridge 2021: meeting abstracts

R. Sullivan, R. Dummer, J. Kirkwood, 2022, Journal of Translational Medicine.

Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences

S. Marnitz, G. Fink, M. Ruge, 2019, The Journal of Nuclear Medicine.

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma.

J. Utikal, D. Schadendorf, V. Sondak, 2017, European journal of cancer.

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.

S. Theurich, N. Skoetz, M. von Bergwelt-Baildon, 2013, The Cochrane database of systematic reviews.

Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients.

C. Berking, A. Hauschild, K. Kähler, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders

A. Gesierich, K. Kähler, L. Heinzerling, 2018, Cancer Immunology, Immunotherapy.

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.

J. Utikal, C. Berking, A. Gesierich, 2017, European journal of cancer.

Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task.

Achim Hekler, Carola Berking, Dirk Schadendorf, 2019, European journal of cancer.

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task.

Achim Hekler, Carola Berking, Dirk Schadendorf, 2019, European journal of cancer.

[Giant basal cell carcinoma on the leg and known HIV infection].

E. Sattler, M. Flaig, A. Wollenberg, 2020, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Primary cutaneous diffuse large B‐cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differences

M. Felcht, C. Klemke, A. Marx, 2019, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis

L. Heinzerling, C. Belka, S. Corradini, 2023, Clinical and translational radiation oncology.

[Personalized medicine in the treatment of periocular tumors : Targeted treatment and use of immune checkpoint inhibitors].

L. Heindl, V. Kakkassery, M. Schlaak, 2020, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma

J. Utikal, D. Schadendorf, B. Schilling, 2020, The British journal of dermatology.

S2k Guidelines – Cutaneous Lymphomas Update 2016 – Part 1: Classification and Diagnosis (ICD10 C82 ‐ C86)

D. Mestel, M. Weichenthal, J. Becker, 2017, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study

U. Wehkamp, L. French, R. Dummer, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

The epidermal polarity protein Par3 is a non–cell autonomous suppressor of malignant melanoma

J. Landsberg, T. Tüting, M. Schlaak, 2017, The Journal of experimental medicine.

Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching

S. Marnitz, M. Hellmich, S. Theurich, 2020, Cancers.

Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single‐center retrospective analysis

M. Schlaak, C. Mauch, O. Persa, 2018, The Journal of dermatology.

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study

J. Utikal, C. Berking, M. Ziemer, 2018, Oncotarget.

Ulcerated Lichen Planus after Adjuvant Use of Programmed Cell Death-1-Inhibitor: A Case Report and Systematic Review of the Literature

A. Niesert, L. French, M. Flaig, 2021, Acta dermato-venereologica.

[Surgical therapy for pulmonary metastases from malignant melanoma].

T. Zander, K. Hekmat, A. Quaas, 2015, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Effectiveness and Tolerability of Ipilimumab: Experiences From 198 Patients Included in a Named-Patient Program in Various Daily-Practice Settings and Multiple Institutions

A. Hauschild, K. Kähler, C. Garbe, 2014, Journal of immunotherapy.

SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry

M. Weichenthal, S. Haferkamp, K. Kähler, 2020, European Journal of Cancer.

Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells

D. Speiser, S. Dirnhofer, S. Theurich, 2014, Cancer Immunology Research.

Robustness of convolutional neural networks in recognition of pigmented skin lesions.

Jakob Nikolas Kather, R. Maron, J. Utikal, 2021, European journal of cancer.

Gene Mutation Mapping in a Fatal Case of Phacomatosis Pigmentokeratotica Happle

L. French, A. Wollenberg, J. Fischer, 2020, Acta dermato-venereologica.

Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification.

Jakob Nikolas Kather, J. Utikal, A. Hekler, 2021, European journal of cancer.

Treatment with tebentafusp beyond radiographic progressive disease (PD) in metastatic uveal melanoma (mUM).

J. Kirkwood, C. Watkins, L. Demidov, 2022, Journal of Clinical Oncology.

Co-primary endpoint of overall survival for tebentafusp (tebe)-induced rash in a phase 3 randomized trial comparing tebe versus investigator’s choice (IC) in first-line metastatic uveal melanoma.

R. Sullivan, R. Dummer, J. Kirkwood, 2021 .

Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis

A. Gesierich, K. Kähler, S. Ugurel, 2022, Data in brief.

Explainable artificial intelligence in skin cancer recognition: A systematic review.

Jakob Nikolas Kather, R. Maron, J. Utikal, 2022, European journal of cancer.

Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition

S. Marnitz, H. Grüll, S. Theurich, 2019, Front. Pharmacol..

Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation

S. Theurich, M. von Bergwelt-Baildon, R. Stadler, 2017, Oncology Research and Treatment.

A benchmark for neural network robustness in skin cancer classification.

Jakob Nikolas Kather, R. Maron, J. Utikal, 2021, European Journal of Cancer.

Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicenter study

U. Wehkamp, L. French, R. Dummer, 2019, European Journal of Cancer.

Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.

A. Krönke, M. Schlaak, P. Kurschat, 2012, European journal of dermatology : EJD.

Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group.

A. Enk, C. Berking, S. Haferkamp, 2020, European journal of cancer.

Predicting risk for seroma development after axillary or inguinal sentinel lymph node biopsy in melanoma patients

M. Schlaak, C. Mauch, O. Persa, 2018, International journal of dermatology.

Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors

L. Heinzerling, M. Ingrisch, J. Dinkel, 2023, Cancer Imaging.

Impact of Perioperative Dexamethasone in the Context of Neurosurgical Brain Metastasis Resection

L. Bullinger, D. Capper, P. Vajkoczy, 2023, medRxiv.

Oligometastatic disease and visceral resections in advanced malignant melanoma: a propensity-matched analysis

C. Mauch, R. Wahba, M. Schlaak, 2023, Langenbeck's Archives of Surgery.

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

M. Weichenthal, J. Utikal, C. Berking, 2022, Cancers.

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis

M. Weichenthal, J. Utikal, C. Berking, 2021, Cancers.

Abstract CT002: Phase 3 randomized trial comparing tebentafusp with investigator's choice in first line metastatic uveal melanoma

R. Sullivan, R. Dummer, J. Kirkwood, 2021, Clinical Trials.

Topical treatment of actinic keratoses with low‐dose 5‐fluorouracil in combination with salicylic acid – pilot study

M. Schlaak, J. Simon, 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Induction of durable responses by oral etoposide monochemotherapy in patients with metastatic Merkel cell carcinoma.

M. Schlaak, P. Kurschat, C. Mauch, 2012, European journal of dermatology : EJD.

Mycobacterium marinum infection initially diagnosed as metastatic Crohn's disease

M. Schlaak, H. Rasokat, M. Schlaak, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Immune checkpoint inhibition and targeted therapy for melanoma: A patient‐oriented cross‐sectional comparative multicentre study

S. Haferkamp, M. Gaiser, R. Gutzmer, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Using Multiple Dermoscopic Photographs of One Lesion Improves Melanoma Classification via Deep Learning: A Prognostic Diagnostic Accuracy Study

Jakob Nikolas Kather, R. Maron, J. Utikal, 2023, ArXiv.

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

J. Utikal, A. Hauschild, S. Haferkamp, 2023, The Lancet.

Granulomatous dermatitis in a 29‐year‐old man from Bangladesh

H. Rasokat, M. Schlaak, M. Fabri, 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient data

H. Alkadhi, D. Maintz, S. Haneder, 2018, European Radiology.

Polymyalgia rheumatica occurring during treatment with ipilimumab

C. Kobe, M. Schlaak, C. Mauch, 2016, EJD. European journal of dermatology.

Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial

M. Weichenthal, J. Utikal, D. Schadendorf, 2023, Frontiers of medicine.

Treatment‐specific evaluation of the modified Glasgow‐Prognostic‐Score in patients with advanced cutaneous melanoma

C. Mauch, S. Theurich, M. Schlaak, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Real‐world outcomes using PD‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

S. Haferkamp, K. Kähler, W. Peitsch, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition

S. Marnitz, H. Grüll, S. Theurich, 2020, Frontiers in Pharmacology.